Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial-Reference-Cited by-同舟云学术

Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial

Published:2020-05-01 Issue:12 Volume:61 Page:1793-1799
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Fendler Wolfgang P.,Ferdinandus Justin,Czernin Johannes,Eiber Matthias,Flavell Robert R.,Behr Spencer C.,Wu I-Wei K.,Lawhn-Heath Courtney,Pampaloni Miguel H.,Reiter Robert E.,Rettig Matthew B.,Gartmann Jeannine,Murthy Vishnu,Slavik Roger,Carroll Peter R.,Herrmann Ken,Calais Jeremie,Hope Thomas A.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference22 articles.

1. Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions—a systematic review and meta-analysis;Perera;Eur Urol.,2020

2. 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and meta-analysis;von Eyben;Eur Urol Focus.,2018

3. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer;Cornford;Eur Urol.,2017

4. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler;J Natl Compr Canc Netw.,2019

5. Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA PET/CT imaging and its application to prostate cancer treatment;Japanese Journal of Radiology;2024-09-03

2. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

3. Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study;Advances in Radiation Oncology;2024-08

4. Prostatic Utricle Cysts as a Potential Pitfall in PSMA PET/CT Interpretation;Clinical Nuclear Medicine;2024-06-20

5. Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer;Seminars in Nuclear Medicine;2024-06